ストックスクリーナーアプリを入手
2.85
5.94%
-0.18
プレマーケット:
2.82
-0.03
-1.05%
前日終値:
$3.03
開ける：
$3.07
24時間の取引高:
542.88K
Relative Volume:
2.96
時価総額：
$127.80M
収益：
$8,000
当期純損益:
$-33.58M
株価収益率:
-3.3384
EPS:
-0.8537
ネットキャッシュフロー:
$-27.88M
1週間 パフォーマンス:
-0.35%
1か月 パフォーマンス:
-2.40%
6か月 パフォーマンス:
-31.33%
1年 パフォーマンス:
-5.63%
1日の値動き範囲:
$2.67
$3.11
1週間の範囲:
$2.67
$3.11
52週間の値動き範囲:
$2.29
$8.535
Genelux Corp Stock (GNLX) Company Profile
名前
Genelux Corp
セクター
電話
805-267-9889
住所
2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE
Compare GNLX vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GNLX
Genelux Corp
|
2.85 | 135.42M | 8,000 | -33.58M | -27.88M | -0.8537 |
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Genelux Corp Stock (GNLX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-21 | 開始されました | Lake Street | Buy |
| 2024-10-29 | 開始されました | Guggenheim | Buy |
| 2024-08-28 | 開始されました | ROTH MKM | Buy |
| 2023-11-27 | 開始されました | H.C. Wainwright | Buy |
| 2023-09-12 | 開始されました | Maxim Group | Buy |
| 2023-02-15 | 開始されました | The Benchmark Company | Speculative Buy |
すべてを表示
Genelux Corp (GNLX) 最新ニュース
Genelux head of regulatory Ralph Smalling sells $562 in stock By Investing.com - Investing.com India
Tax-related share sale by Genelux (GNLX) Head of Regulatory - Stock Titan
Genelux head of regulatory Ralph Smalling sells $562 in stock - Investing.com
Genelux director Thomas John sold $29,801 in company stock By Investing.com - Investing.com India
Insider Sell: John Thomas Sells 10,000 Shares of Genelux Corp (G - GuruFocus
Genelux director Thomas John sold $29,801 in company stock - Investing.com
GENELUX (NASDAQ: GNLX) director sells 10,000 shares in Rule 10b5-1 trade - Stock Titan
Genelux Corp. Financial Disclosures & SEC Filings - TradingView
GNLX (NASDAQ) director sells 10,000 shares via 10b5-1, $28,957 proceeds - Stock Titan
GNLX Q1 2026 Earnings: EPS Miss Amid Pre-Revenue Development Stage; Stock Edges HigherAnnual Earnings Summary - newsline.com
GNLX Q1 2026 Earnings: EPS Misses Estimates as Company Reports No RevenueEarnings Surprise Stocks - newsline.com
GNLX SEC FilingsGenelux Corp 10-K, 10-Q, 8-K Forms - Stock Titan
GNLX Technical Analysis | Trend, Signals & Chart Patterns | GENELUX CORP (NASDAQ:GNLX) - ChartMill
Genelux president and CEO Zindrick Thomas sells $8,225 in stock By Investing.com - Investing.com Nigeria
Genelux CSO Yu Yong sells $1,798 of common stock - Investing.com UK
Genelux CSO Yu Yong sells $1,798 of common stock By Investing.com - Investing.com Nigeria
Genelux CTO Joseph Cappello sells $1,799 in company stock By Investing.com - Investing.com South Africa
Genelux head of regulatory sells $804 in stock By Investing.com - Investing.com Nigeria
Genelux president and CEO Zindrick Thomas sells $8,225 in stock - Investing.com
Genelux CTO Joseph Cappello sells $1,799 in company stock - Investing.com
Genelux head of regulatory sells $804 in stock - Investing.com
Genelux (GNLX) CSO Yu Yong sells 605 shares to cover RSU tax bill - Stock Titan
Research Analysts Offer Predictions for Genelux Q2 Earnings - MarketBeat
Buy Rating Reaffirmed on Olvi-Vec Progress and Data Outlook; $31 Price Target Maintained - TipRanks
Genelux : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) - marketscreener.com
Ovarian cancer trial readout due in 2H26 as Genelux cash lasts to 1Q27 - Stock Titan
GENELUX Corp 1Q 2026: Revenue $0 Net loss $8.9M, EPS $(0.20) — 10-Q Summary - TradingView
Genelux (GNLX) raises $18.5M, extends cash runway into 2027 - Stock Titan
Genelux Corporation Reports First Quarter Financial Results and Provides Business Updates - Yahoo Finance
GNLX Stock Price, Quote & Chart | GENELUX CORP (NASDAQ:GNLX) - ChartMill
Genelux Corp expected to post a loss of 18 cents a shareEarnings Preview - TradingView
[ARS] GENELUX Corp SEC Filing - Stock Titan
Genelux (NASDAQ: GNLX) details 2026 virtual meeting, board and auditor votes - Stock Titan
Genelux (GNLX) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
Olvi Vec could reshape advanced ovarian cancer treatment, Genelux claims - Traders Union
Genelux Corporation (GNLX) Stock: Technical Signals (Technical Weakness) 2026-04-20Live Trade Sharing - Newser
Genelux Corp (GNLX) 財務データ
収益
当期純利益
現金流量
EPS
Genelux Corp (GNLX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Thomas John | Director |
Jun 01 '26 |
Sale |
2.98 |
10,000 |
29,801 |
472,784 |
2.60%
0.94%
大文字化:
|
ボリューム (24 時間):